Neural correlates of delayed episodic memory in patients with mild cognitive impairment-A FDG PET study

Neuroscience Letters

Volumn 467, Issue 2, 2009, Pages 100-104

  Schönknecht, Oskar Dieter Peter ^a,b   Hunt, Aoife ^b   Toro, Pablo ^b   Henze, Marcus ^b   Haberkorn, Uwe ^b   Schröder, Johannes ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Episodic memory; FDG PET; Mild cognitive impairment; Neural correlates

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPISODIC MEMORY; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; COGNITION DISORDERS; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GLUCOSE; HUMANS; MALE; MEMORY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; VERBAL BEHAVIOR;

EID: 70350574036     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.014     Document Type: Article

References (40)

1. Anchisi D., Borroni B., Franceschi M., Kerrouche N., Kalbe E., Beuthien-Beumann B., Cappa S., Lenz O., Ludecke S., Marcone A., Mielke R., Ortelli P., Padovani A., Pelati O., Pupi A., Scarpini E., Weisenbach S., Herholz K., Salmon E., Holthoff V., Sorbi S., Fazio F., and Perani D. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch. Neurol. 62 (2005) 1728-1733
2. Baron J., Chételat G., Perchey G., Poline J., Landeau B., Desgranges B., de la Sayette V., and Eustache F. Does resting glucose hypometabolism exceed gray matter atrophy in early Alzheimer's disease (AD)? A voxel-based comparison of structural and functional imaging data. Neuroimage 13 (2001) 771
3. Barth S., Schönknecht P., Pantel J., and Schröder J. Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery. Fortschr. Neurol. Psychiat. 73 (2005) 568-576
4. Becker J.T., Mintun M.A., Aleva K., Wiseman M.B., Nichols T., and DeKosky S.T. Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology 46 (1996) 692-700
5. Bokde A.L., Pietrini P., Ibanez V., Furey M.L., Alexander G.E., Graff-Radford N.R., Rapoport S.I., Schapiro M.B., and Horwitz B. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch. Neurol. 58 (2001) 480-486
6. Bokde A.L.W., Teipel S.J., Drzezga A., Thissen J., Bartenstein P., Dong W., Leinsinger G., Born C., Schwaiger M., Moeller H.-J., and Hampel H. Association between performance and cortical glucose metabolism in patients with mild Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 20 (2005) 352-357
7. Bracco L., Bessi V., Piccini C., Mosconi L., Pupi A., and Sorbi S. Metabolic correlates of executive dysfunction: different patterns in mild and very mild Alzheimer's disease. J. Neurol. 54 (2007) 1052-1065
8. Cabeza R., and Nyberg L. Imaging cognition. II. An empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12 (2000) 1-47
9. Chetelat G., Desgranges B., De La Sayette V., Viader F., Eustache F., and Baron J.C. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology 60 (2003) 1374-1377
10. Desgranges B., Baron J.C., and Eustache F. The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas. Neuroimage 8 (1998) 198-213
11. Desgranges B., Baron J.C., de la Sayette V., Petit-Taboue M.C., Benali K., Landeau B., Lechevalier B., and Eustache F. The neural substrates of memory systems impairment in Alzheimer's disease, A PET study of resting brain glucose utilization. Brain 121 (1998) 611-631
12. Desgranges B., Baron J.C., Lalevée C., Giffard B., Viader F., de la Sayette V., and Eustache F. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain 125 (2002) 1116-1124
13. Drzezga A., Grimmer T., Riemenschneider M., Lautenschlager N., Siebner H., Alexopoulus P., Minoshima S., Schwaiger M., and Kurz A. Prediction of individual outcome in MCI by means of genetic assessment and 18F-FDG PET. J. Nucl. Med. 46 (2005) 1625-1632
14. Dubois B., Feldman H.H., Jacova C., DeKosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., and Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6 (2007) 734-746
15. Evans K.C., Banzett R.B., Adams L., McKay L., Frackowiak R.S., and Corfield D.R. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J. Neurophysiol. 88 (2002) 1500-1511
16. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
17. Friston K., Holmes A., Worsley K., Poline J., Frith C., and Frackowiak R. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2 (1995) 189-210
18. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frölich L., Schönknecht P., Ito K., Mielke R., Kalbe E., Zundorf G., Delbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schröder J., Kato T., Arahata Y., Henze M., and Heiss W.D. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17 (2002) 302-316
19. Hunt A., Schönknecht P., Henze M., Seidl U., Haberkorn U., and Schröder J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiat. Res. Neuroimag. 155 (2007) 147-154
20. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., and Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50 (1998) 1585-1593
21. Kalpouzos G., Eustache F., de la Sayette V., Viader F., Chételat G., and Desgranges B. Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients. J. Neurol. 252 (2005) 548-558
22. G. Kalpouzos, J.C. Chételat, B. Baron, K. Landeau, C. Mevel, L. Godeau, J.M. Barré, J.M. Constans, F. Viader, F. Eustache, B. Desgranges, Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging, Neurobiol. Aging (2007) Epub ahead of print.
23. Loeb C., and Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 14 (1983) 399-401
24. Mitchell A.J. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease-a meta-analysis of 51 studies. J. Neurol. Neurosurg. Psychiat. 80 (2009) 966-975
25. Mitchell A.J., and Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiat. Scand. 199 (2009) 252-265
26. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., and Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 (1989) 1159-1165
27. Mosconi L., Pupi A., and De Leon M.J. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann. N.Y. Acad. Sci. 1147 (2008) 180-195
28. Mosconi L., Perani D., Sorbi S., Herholz K., Nacmias B., Holthoff V., Salmon E., Baron J.C., De Cristofaro M.T., Padovani A., Borroni B., Franceschi M., Bracco L., and Pupi A. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63 (2004) 2332-2340
29. Nestor P.J., Fryer T.D., Smielewski P., and Hodges J.R. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 54 (2003) 343-351
30. Pantel J., Kratz B., Essig M., and Schröder J. Parahippocampal volume deficits in subjects with aging-associated cognitive decline. Am. J. Psychiatry 160 (2003) 379-382
31. Petersen C.P., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., and Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001) 1985-1992
32. Sanfey A.G., Rilling J.K., Aronson J.A., Nystrom L.E., and Cohen J.D. The neural basis of economic decision-making in the Ultimatum Game. Science 300 (2003) 1755-1758
33. Scarmeas N., Zarahn E., Anderson K.E., Habeck C.G., Hilton J., Flynn J., Marder K.S., Bell K.L., Sackheim H.A., van Heertum R.L., Moeller J.R., and Stern Y. Association if life activities with cerebral blood flow in Alzheimer disease. Arch. Neurol. 60 (2003) 359-365
34. Schönknecht P., Pantel J., Kaiser E., Thomann P., and Schröder J. Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia. Neurosci. Lett. 416 (2007) 39-42
35. Schönknecht P., Pantel J., Kruse A., and Schröder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am. J. Psychiatry 162 (2005) 2071-2077
36. Schröder J., Buchsbaum M.S., Shihabuddin L., Tang C., Wei T.C., Spiegel-Cohen J., Hazlett E.A., Abel L., Luu-Hsia C., Ciaravolo T.M., Marin D., and Davis K.L. Patterns of cortical activity and memory performance in Alzheimer's disease. Biol. Psychiatry 49 (2001) 426-436
37. Silverman D.H.S., Truong C.T., Kim S.K., Chang C.Y., Chen W., Kowell A.P., Cummings J.L., Czernin J., Small G.W., and Phelps M.E. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol. Genet. Metab. 80 (2003) 350-355
38. J. Talairach, P. Tournoux, Co-planar Stereotaxic Atlas of the Human Brain, Paris, Thieme (1988).
39. Teipel S.J., Willoch F., Ishii K., Bürger K., Drzezga A., Engel R., Bartenstein P., Möller H.J., Schwaiger M., and Hampel H. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease. Neurobiol. Aging 27 (2005) 681-690
40. Thomas K.M., Hunt R.H., Vizueta N., Sommer T., Durston S., Yang Y., and Worden M.S. Evidence of developmental differences in implicit sequence learning: an fMRI study of children and adults. J. Cogn. Neurosci. 16 (2004) 1339-1351